These two Fate series are a great way to pass the time until an official release date drops for the first season of ...

The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

The "World Market for Apparel and Footwear" report has been added to ResearchAndMarkets.com's offering.This report explores how fashion players can redefine their value beyond price to attract ...

Councillors have approved a new plan to boost jobs and growth in Stoke-on-Trent. Stoke-on-Trent City Council's economic ...

Bitcoin's surge to a new all-time high and its 162% price increase over the past year signals growing mainstream interest in ...

January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, all ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

Sage Therapeutics has a unique approach to targeting GABA, which allows it to target CNS disorders. Read why I think SAGE ...

H.C. Wainwright reaffirmed its Buy rating on shares of Legend Biotech Corp . (NASDAQ:LEGN) shares, maintaining a $73.00 price ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...